Literature DB >> 17325746

Telomere attrition in isolated high-grade prostatic intraepithelial neoplasia and surrounding stroma is predictive of prostate cancer.

Anthony Michael Joshua1, Bisera Vukovic, Ilan Braude, Sundus Hussein, Maria Zielenska, John Srigley, Andrew Evans, Jeremy Andrew Squire.   

Abstract

The causes of early genomic events underlying the development of prostate cancer (CaP) remain unclear. The onset of chromosomal instability is likely to facilitate the formation of crucial genomic aberrations both in the precursor lesion high-grade prostatic intraepithelial neoplasia (HPIN) and in CaP. Instability generated by telomere attrition is one potential mechanism that could initiate chromosomal rearrangements. In this study, normalized telomere length variation was examined in a cohort of 68 men without CaP who had HPIN only on prostatic biopsies. Multiple significant associations between telomere attrition and eventual diagnosis of CaP in the HPIN and in the surrounding stroma were found. Kaplan-Meier analysis of telomere length demonstrated a significantly increased risk for the development of cancer with short telomeres in the surrounding stroma [P = .035; hazard ratio (HR) = 2.12; 95% confidence interval (95% CI) = 0.231-0.956], and a trend for HPIN itself (P = .126; HR = 1.72; 95% CI = 0.287-1.168). Cox regression analysis also demonstrated significance between the time from the original biopsy to the diagnosis of cancer and telomere length in HPIN and in the surrounding stroma. These analyses showed significance, both alone and in combination with baseline prostate-specific antigen, and lend support to the hypothesis that telomere attrition in prostatic preneoplasia may be fundamental to the generation of chromosomal instability and to the emergence of CaP.

Entities:  

Mesh:

Year:  2007        PMID: 17325746      PMCID: PMC1803037          DOI: 10.1593/neo.06745

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  43 in total

1.  Site-specific DNA damage at the GGG sequence by UVA involves acceleration of telomere shortening.

Authors:  S Oikawa; S Tada-Oikawa; S Kawanishi
Journal:  Biochemistry       Date:  2001-04-17       Impact factor: 3.162

Review 2.  A critical role for telomeres in suppressing and facilitating carcinogenesis.

Authors:  S E Artandi; R A DePinho
Journal:  Curr Opin Genet Dev       Date:  2000-02       Impact factor: 5.578

3.  TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions.

Authors:  Nuno Cerveira; Franclim R Ribeiro; Ana Peixoto; Vera Costa; Rui Henrique; Carmen Jerónimo; Manuel R Teixeira
Journal:  Neoplasia       Date:  2006-10       Impact factor: 5.715

4.  Interphase FISH analysis of PTEN in histologic sections shows genomic deletions in 68% of primary prostate cancer and 23% of high-grade prostatic intra-epithelial neoplasias.

Authors:  Maisa Yoshimoto; Jean-Claude Cutz; Paulo A S Nuin; Anthony M Joshua; Jane Bayani; Andrew J Evans; Maria Zielenska; Jeremy A Squire
Journal:  Cancer Genet Cytogenet       Date:  2006-09

5.  Immunodetection of human telomerase reverse-transcriptase (hTERT) re-appraised: nucleolin and telomerase cross paths.

Authors:  Ying-Li Wu; Charles Dudognon; Eric Nguyen; Josette Hillion; Frédéric Pendino; Ilona Tarkanyi; Janos Aradi; Michel Lanotte; Jian-Hua Tong; Guo-Qiang Chen; Evelyne Ségal-Bendirdjian
Journal:  J Cell Sci       Date:  2006-06-13       Impact factor: 5.285

6.  Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer.

Authors:  Bharathi Laxman; Scott A Tomlins; Rohit Mehra; David S Morris; Lei Wang; Beth E Helgeson; Rajal B Shah; Mark A Rubin; John T Wei; Arul M Chinnaiyan
Journal:  Neoplasia       Date:  2006-10       Impact factor: 5.715

7.  ATM activation is accompanied with earlier stages of prostate tumorigenesis.

Authors:  Catherine Fan; Rebecca Quan; Xinchang Feng; Aubrey Gillis; Lizhi He; Edward D Matsumoto; Sam Salama; Jean-Claude Cutz; Anil Kapoor; Damu Tang
Journal:  Biochim Biophys Acta       Date:  2006-08-24

8.  Hepatocyte growth factor secreted by prostate-derived stromal cells stimulates growth of androgen-independent human prostatic carcinoma cells.

Authors:  K Nakashiro; M Okamoto; Y Hayashi; R Oyasu
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

9.  The pathological response to DNA damage does not contribute to p53-mediated tumour suppression.

Authors:  M A Christophorou; I Ringshausen; A J Finch; L Brown Swigart; G I Evan
Journal:  Nature       Date:  2006-09-06       Impact factor: 49.962

Review 10.  p53-Dependent and -independent functions of the Arf tumor suppressor.

Authors:  C J Sherr; D Bertwistle; W DEN Besten; M-L Kuo; M Sugimoto; K Tago; R T Williams; F Zindy; M F Roussel
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2005
View more
  16 in total

1.  The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancer.

Authors:  Lisa Mirabello; Wen-Yi Huang; Jason Y Y Wong; Nilanjan Chatterjee; Douglas Reding; E David Crawford; Immaculata De Vivo; Richard B Hayes; Sharon A Savage
Journal:  Aging Cell       Date:  2009-06-01       Impact factor: 9.304

2.  Organ-wide telomeric status in diseased and disease-free prostatic tissues.

Authors:  Christopher M Heaphy; Trisha M Fleet; Eric G Treat; Sang-Joon Lee; Anthony Y Smith; Michael S Davis; Jeffrey K Griffith; Edgar G Fischer; Marco Bisoffi
Journal:  Prostate       Date:  2010-09-15       Impact factor: 4.104

Review 3.  Molecular genetics of prostate cancer: new prospects for old challenges.

Authors:  Michael M Shen; Cory Abate-Shen
Journal:  Genes Dev       Date:  2010-09-15       Impact factor: 11.361

4.  The War on Cancer rages on.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

5.  Neoplasia: the second decade.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

6.  Telomere DNA content in prostate biopsies predicts early rise in prostate-specific antigen after radical prostatectomy for prostate cancer.

Authors:  Eric G Treat; Christopher M Heaphy; Larry W Massie; Marco Bisoffi; Anthony Y Smith; Michael S Davis; Jeffrey K Griffith
Journal:  Urology       Date:  2009-07-16       Impact factor: 2.649

7.  Leukocyte telomere length in a population-based case-control study of ovarian cancer: a pilot study.

Authors:  Lisa Mirabello; Montserrat Garcia-Closas; Richard Cawthon; Jolanta Lissowska; Louise A Brinton; Beata Pepłońska; Mark E Sherman; Sharon A Savage
Journal:  Cancer Causes Control       Date:  2009-09-27       Impact factor: 2.506

8.  Telomere attrition in cancer cells and telomere length in tumor stroma cells predict chromosome instability in esophageal squamous cell carcinoma: a genome-wide analysis.

Authors:  Yun-Ling Zheng; Nan Hu; Qing Sun; Chaoyu Wang; Philip R Taylor
Journal:  Cancer Res       Date:  2009-02-03       Impact factor: 12.701

9.  Telomere dynamics in keloids.

Authors:  Mark Granick; Masayuki Kimura; Soyeon Kim; Lily Daniali; Xiaojian Cao; Utz Herbig; Abraham Aviv
Journal:  Eplasty       Date:  2011-03-16

10.  Shortened telomere length is associated with increased risk of cancer: a meta-analysis.

Authors:  Hongxia Ma; Ziyuan Zhou; Sheng Wei; Zhensheng Liu; Karen A Pooley; Alison M Dunning; Ulrika Svenson; Göran Roos; H Dean Hosgood; Min Shen; Qingyi Wei
Journal:  PLoS One       Date:  2011-06-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.